SCHEMBL6028115

SCHEMBL6028115

NC(=O)c1cccc2cc(-c3cnc4ccccc4c3)[nH]c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.50
PARP1 P09874 5/20 0.49
MAP4K4 O95819 2/20 0.45
CLK4 Q9HAZ1 2/20 0.45
CSNK1G2 P78368 1/20 0.45
MKNK2 Q9HBH9 1/20 0.45
MAP4K5 Q9Y4K4 1/20 0.45
PDGFRA P16234 2/20 0.45
PLK4 O00444 1/20 0.45
CHEK1 O14757 1/20 0.45
AURKA O14965 1/20 0.45
DAPK3 O43293 1/20 0.45
CSF1R P07333 1/20 0.45
RET P07949 1/20 0.45
FGFR1 P11362 1/20 0.45
LTK P29376 1/20 0.45
KDR P35968 1/20 0.45
MAP2K2 P36507 1/20 0.45
FLT3 P36888 1/20 0.45
CSNK1A1 P48729 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5077264 0.83 PARP1 (0.47) DHODHPARP1MAP4K4CLK4CSNK1G2
SCHEMBL6028881 0.82 PLK4 (0.45) DHODHPARP1MAP4K4CLK4PDGFRA
SCHEMBL6028084 0.80 DHODH (0.59) DHODHPARP1MAP4K4CLK4PDGFRA
SCHEMBL6029606 0.79 DHODH (0.78) DHODHPARP1MAP4K4CLK4PDGFRA
SCHEMBL6029671 0.78 DHODH (0.68) DHODHPARP1MAP4K4CLK4PDGFRA
SCHEMBL6029520 0.78 CDC7 (0.62) DHODHMAP4K4CLK4MKNK2PLK4
SCHEMBL31127659 0.77 PARP1 (0.54) PARP1MAP4K4CLK4CSNK1G2MKNK2
SCHEMBL995473 0.77 PARP1 (0.54) PARP1MAP4K4CLK4CSNK1G2MKNK2
SCHEMBL6028712 0.77 DHODH (0.46) DHODHPARP1MAP4K4CLK4CSNK1G2
SCHEMBL6029110 0.77 BTK (0.57) DHODHPARP1MAP4K4CLK4MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7087637-B2 Substituted indoles which are PARP inhibitors BASF AG (DE) 2006-08-08 US disclosed
US-20040067949-A1 Substituted indoles which are parp inhibitors ABBVIE DEUTSCHLAND GMBH & CO KG (DE) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067949-A1 Substituted indoles which are parp inhibitors PARP1, PARP2, PARP12 DHODH 674/4885PARP1 1/4885MAP4K4 1754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.